8,16,18,26,34,36-Hexahydroxy-2,6,10,14,24,28,32-hentetracontaneheptone (73356-03-3)

Identification
Name:	8,16,18,26,34,36-Hexahydroxy-2,6,10,14,24,28,32-hentetracontaneheptone
Synonyms:	8,16,18,26,34,36-Hexahydroxy-2,6,10,14,24,28,32-hentetracontaneheptone;Toxin 2
CAS:	73356-03-3
Molecular Formula:	C₄₁H₇₀O₁₃
Molecular Weight:	0
InChI:	InChI=1/C41H70O13/c1-3-4-6-13-30(43)21-38(51)25-34(47)17-10-18-35(48)26-39(52)22-31(44)14-7-5-8-15-32(45)23-40(53)27-36(49)19-11-20-37(50)28-41(54)24-33(46)16-9-12-29(2)42/h30,32,38-41,43,45,51-54H,3-28H2,1-2H3
Molecular Structure:
Properties
Flash Point:	536.2°C
Boiling Point:	940.2°C at 760 mmHg
Density:	1.146g/cm³
Refractive index:	1.51
Flash Point:	536.2°C
Safety Data

Other Product

1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H
Neuropeptide Y (human),24-L-leucinamide-25-de-L-arginine-26-de-L-histidine-27-de-L-tyrosine-28-de-L-isoleucine-29-de-L-asparagine-30-de-L-leucine-31-de-L-isoleucine-32-de-L-threonine-33-de-L-arginine-34-de-L-glutamine-35-de-L-arginine-36-de-L-tyrosinamide-(9CI)
1/C19H20O5/c1-11(2)7-18(21)24-19(3,4)16-9-13-8-12-5-6-17(20)23-14(12)10-15(13)22-16/h5-8,10,16H,9H2,1-4H
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H
3-36-Neuropeptide Y(swine), 3-L-alanine-6-L-glutamicacid-7-L-alanine-13-L-serine-14-L-proline-16-L-glutamicacid-18-L-serine-22-L-alanine-23-L-serine-28-L-leucine-31-L-valine- (9CI)
1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H